JNCE - Jounce Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts6666
Avg. Estimate-0.35-0.37-1.29-1.22
Low Estimate-0.42-0.48-1.44-2.33
High Estimate-0.28-0.28-1.11-0.25
Year Ago EPS-0.13-0.29-0.57-1.29
Revenue EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts6666
Avg. Estimate13.13M12.61M56.46M68.55M
Low Estimate11M10.68M53M43M
High Estimate15.5M15.5M61.57M86.25M
Year Ago Sales18.08M12.99M71.64M56.46M
Sales Growth (year/est)-27.40%-2.90%-21.20%21.40%
Earnings History9/29/201712/30/20173/30/20186/29/2018
EPS Est.-0.25-0.49-0.31-0.37
EPS Actual-0.13-0.29-0.4-0.14
Difference0.120.2-0.090.23
Surprise %48.00%40.80%-29.00%62.20%
EPS TrendCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.35-0.37-1.29-1.22
7 Days Ago-0.39-0.4-1.56-1.43
30 Days Ago-0.39-0.4-1.56-1.43
60 Days Ago-0.38-0.39-1.54-1.35
90 Days Ago-0.12-0.42-1.29-1.14
EPS RevisionsCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Up Last 7 Days435N/A
Up Last 30 Days4353
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/A1N/A1
Growth EstimatesJNCEIndustrySectorS&P 500
Current Qtr.-169.20%N/AN/A0.47
Next Qtr.-27.60%N/AN/A0.46
Current Year-126.30%N/AN/A0.22
Next Year5.40%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A